Ünal Metin Tokat
8PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 14, 2024
Elacestrant plus alpelisib in an ESR1 and PIK3CA co-mutated and heavily pretreated metastatic breast cancer: the first case report for combination efficacy and safety.Ünal Metin Tokat, Şevval Nur Bilgiç, Esranur Aydın
|Jun 15, 2024
Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer.Ozge Saatci, Rashedul Alam, Kim-Tuyen Huynh-Dam
|Apr 22, 2024
Navigating uncharted territory: a case report and literature review on the remarkable response to personalized crizotinib containing combinational therapy in a pazopanib refractory patient with novel alterations.Esranur Aydın, Ünal Metin Tokat, Eylül Özgü
|Dec 18, 2023
PARP inhibitor combinations with high-dose vitamin C in the treatment of Ewing sarcoma: two case reports and mechanistic overview.Ashkan Adibi, Ünal Metin Tokat, Eylül Özgü
|Nov 02, 2023
Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer.Ozge Saatci, Metin Cetin, Meral Uner
|Feb 03, 2022
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin.Marco Biondini, Alex Kiepas, Leeanna El-Houjeiri
Pageof 2
Frequent Collaborators
4 joint publications
Ozgur Sahin
4 joint publications
Eylül Özgü
4 joint publications
Mutlu Demiray
4 joint publications
Esranur Aydın
3 joint publications
Ashkan Adibi
3 joint publications
Pelin Gulizar Ersan
3 joint publications
Sercan Aksoy
2 joint publications
Şevval Nur Bilgiç
2 joint publications
Meral Uner
2 joint publications
Ozge Saatci
